He, Chao <br/><br/>
Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin.  [electronic resource] 

 -  Clinical epigenetics  01 2019 
 - 8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1868-7083 
<br/><br/><label>Standard No.: </label>10.1186/s13148-018-0605-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cisplatin--administration & dosage<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Enhancer of Zeste Homolog 2 Protein--genetics<br/>Epigenesis, Genetic<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Histone Demethylases--genetics<br/>Histones--metabolism<br/>Humans<br/>Jumonji Domain-Containing Histone Demethylases--genetics<br/>Male<br/>Mice<br/>Myeloid Cell Leukemia Sequence 1 Protein--genetics<br/>Nuclear Proteins--genetics<br/>Osteosarcoma--drug therapy<br/>Protein Kinase C-alpha--genetics<br/>Sequence Analysis, RNA<br/>Up-Regulation<br/>Xenograft Model Antitumor Assays